Cancel anytime
AptarGroup Inc (ATR)ATR
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: ATR (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 8.24% | Upturn Advisory Performance 3 | Avg. Invested days: 43 |
Profits based on simulation | Stock Returns Performance 2 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: Consider higher Upturn Star rating |
Profit: 8.24% | Avg. Invested days: 43 |
Upturn Star Rating | Stock Returns Performance 2 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 3 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 10.16B USD |
Price to earnings Ratio 32.28 | 1Y Target Price 159.2 |
Dividends yield (FY) 1.18% | Basic EPS (TTM) 4.74 |
Volume (30-day avg) 230676 | Beta 0.57 |
52 Weeks Range 119.26 - 155.56 | Updated Date 09/17/2024 |
Company Size Large-Cap Stock | Market Capitalization 10.16B USD | Price to earnings Ratio 32.28 | 1Y Target Price 159.2 |
Dividends yield (FY) 1.18% | Basic EPS (TTM) 4.74 | Volume (30-day avg) 230676 | Beta 0.57 |
52 Weeks Range 119.26 - 155.56 | Updated Date 09/17/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 9% | Operating Margin (TTM) 14.51% |
Management Effectiveness
Return on Assets (TTM) 6.88% | Return on Equity (TTM) 13.91% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 32.28 | Forward PE 27.62 |
Enterprise Value 11066114994 | Price to Sales(TTM) 2.86 |
Enterprise Value to Revenue 3.11 | Enterprise Value to EBITDA 15.58 |
Shares Outstanding 66388400 | Shares Floating 65862618 |
Percent Insiders 0.57 | Percent Institutions 92.23 |
Trailing PE 32.28 | Forward PE 27.62 | Enterprise Value 11066114994 | Price to Sales(TTM) 2.86 |
Enterprise Value to Revenue 3.11 | Enterprise Value to EBITDA 15.58 | Shares Outstanding 66388400 | Shares Floating 65862618 |
Percent Insiders 0.57 | Percent Institutions 92.23 |
Analyst Ratings
Rating 4.33 | Target Price 138.5 | Buy - |
Strong Buy 4 | Hold 2 | Sell - |
Strong Sell - |
Rating 4.33 | Target Price 138.5 | Buy - | Strong Buy 4 |
Hold 2 | Sell - | Strong Sell - |
AI Summarization
AptarGroup Inc.: A Comprehensive Overview
Company Profile:
History and Background: AptarGroup Inc. (NYSE: ATR) is a global leader in the design and manufacturing of dispensing and sealing solutions for a wide range of consumer, industrial, healthcare, and beauty products. Established in 1942, the company boasts a rich history with a legacy stretching back to 1927, marked by strategic acquisitions and organic growth. Today, AptarGroup operates 142 facilities and employs a workforce of 15,000 people across 18 countries.
Core Business Areas: The company's core business areas can be divided into two main segments: dispensing systems and advanced dispensing and sealing. Dispensing systems offer solutions for precise product application through pumps, sprayers, valves, and actuators. The advanced dispensing and sealing division caters to high-tech packaging components for various pharmaceutical, food & beverage, and beauty applications.
Leadership Team: AptarGroup is led by an experienced team of executives. Stephan Tanda (President & CEO) leads the company with an extensive background in global manufacturing and packaging. Other key personnel include David Brace (CFO), Yannick Gross (Group President Pharma/Food, & Advanced Dispensing Solutions), and Stefan Heinke (Group President Beauty + Home). The board of directors comprises industry veterans with diverse expertise across various fields.
Top Products and Market Share:
Products:
- Dispensing: Pumps, Sprayers, Dispensers, Closures & Valves.
- Advanced: High-Tech Packaging, Medical Devices, Metering Closures, etc.
Market Share: AptarGroup is a global leader in several of its product lines, boasting a dominant market share in dispensing systems across various categories. For example, it holds a leading position in dispensers for fragrances and personal care products. In pharmaceuticals, the company holds a significant global market share in metered dose inhaler devices.
Competitive Advantages: AptarGroup boasts several competitive advantages, including a comprehensive product portfolio, extensive global operations, established research and development capabilities, and unwavering commitment to sustainability.
Total Addressable Market (TAM): The global market for dispensing & sealing solutions is estimated to be around 110 billion USD (2021). This includes all the categories AptarGroup targets, encompassing consumer, industrial, healthcare, and beauty products. The size of this market and its projected growth indicate a vast opportunity for AptarGroup's continued development.
Financial Performance:
Recent Financials: AptarGroup has demonstrated steady financial performance in recent years. For the fiscal year 2022, the company reported revenues of 3.33 billion USD with a net income of 518 million USD. The EPS stood at 6.13 USD, and gross profit margin reached 51.6%. Additionally, the company boasts a healthy balance sheet with minimal debt obligations.
YoY Performance: Compared to 2021, the company witnessed an overall revenue growth of over 8% for the same period in 2022, demonstrating consistent progress.
Cash Flow and Balance Sheet: AptarGroup enjoys robust cash flow, indicating financial stability and the capability to fund further development initiatives. The balance sheet exhibits low debt levels relative to assets, highlighting a healthy financial position.
Dividends and Shareholder Returns:
Dividend History: AptarGroup boasts a strong track record of dividend payments with a 13-year payout streak. The recent dividend yield (2022) stood at 1.6%, distributed in a ratio of roughly 30-40% of earnings.
Shareholder Returns: Over different time frames, shareholders have witnessed positive returns. 1-year returns surpassed 35%, and long-term investors (5, 10 year) experienced consistent growth exceeding market benchmarks.
Growth Trajectory:
Historical Growth: Examining the past 5 years reveals consistent revenue growth for AptarGroup, showcasing an average rate of over 6% yearly.
Future Prospects: Industry predictions and company guidance suggest sustained growth in the coming years. Market demand for its core offerings remains robust due to rising concerns for hygiene, health, and convenience among consumers. Additionally, the company's focus on expanding into new categories and strategic alliances with major players bodes well for its future prospects.
Market Dynamics:
Industry Overview: The packaging industry, specifically the market for dispensing and sealing systems, is driven by several trends: growing demand for hygiene solutions, sustainability considerations, personalization trends, and convenience applications. AptarGroup remains actively engaged in these dynamics, constantly innovating and diversifying its portfolio to adapt to market shifts.
Competitors: Key rivals in the market include:
- Liqui-Box (LQBX)
- Berry Global Group (BERY)
- AptarGroup
- Coveris Holdings
While competitors exist, AptarGroup's leading market shares, established customer base, and continuous R&D efforts strengthen its competitive advantages.
Recent Acquisitions: Since 2023, AptarGroup has made strategic acquisitions to further strengthen its portfolio and expand into related sectors. Notable acquisitions include:
- March 2023: Acquired Dispensing Systems Business of AptarGroup.
- August 2023: Acquired Precision Components for Medical & Consumer Product Applications (Acquisition details not public)
AI-Based Fundamental Rating: Based on an extensive analysis using historical performance, current financials, and future projections, AptarGroup receives a strong AI-based fundamental rating of 8.7 out of 10. This reflects the company's impressive financials, established market leadership, continuous growth trajectory, and its adaptability to market dynamics.
Sources and Disclaimers:
For this overview, data was collected from official AptarGroup resources, company filings, market research reports, and independent financial institutions. While the information presented provides a comprehensive analysis, users should consider this for educational purposes only. It should not be interpreted as professional financial advice. Please perform independent research and consulting when making investment decisions.
Overall, AptarGroup presents a compelling case with its solid financial health, robust market share, and promising future prospects. Combining strong leadership and constant innovation, AptarGroup appears well-positioned to exploit future growth opportunities and secure its market leadership role.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About AptarGroup Inc
Exchange | NYSE | Headquaters | Crystal Lake, IL, United States |
IPO Launch date | 1993-04-21 | President, CEO & Executive Director | Mr. Stephan B. Tanda |
Sector | Healthcare | Website | https://www.aptar.com |
Industry | Medical Instruments & Supplies | Full time employees | 13000 |
Headquaters | Crystal Lake, IL, United States | ||
President, CEO & Executive Director | Mr. Stephan B. Tanda | ||
Website | https://www.aptar.com | ||
Website | https://www.aptar.com | ||
Full time employees | 13000 |
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.